Polarization of Na(+)/H(+) and Cl(-)/HCO (3)(-) exchangers in migrating renal epithelial cells.
Cell migration is crucial for processes such as immune defense, wound healing, or the formation of tumor metastases. Typically, migrating cells are polarized within the plane of movement with lamellipodium and cell body representing the front and rear of the cell, respectively. Here, we address the question of whether this polarization also extends to the distribution of ion transporters such as Na(+)/H(+) exchanger (NHE) and anion exchanger in the plasma membrane of migrating cells. Both transporters are required for locomotion of renal epithelial (Madin-Darby canine kidney, MDCK-F) cells and human melanoma cells since their blockade reduces the rate of migration in a dose-dependent manner. Inhibition of migration of MDCK-F cells by NHE blockers is accompanied by a decrease of pH(i). However, when cells are acidified with weak organic acids, migration of MDCK-F cells is normal despite an even more pronounced decrease of pH(i). Under these conditions, NHE activity is increased so that cells are swelling due to the accumulation of organic anions and Na(+). When exclusively applied to the lamellipodium, blockers of NHE or anion exchange inhibit migration of MDCK-F cells as effectively as when applied to the entire cell surface. When they are directed to the cell body, migration is not affected. These data are confirmed immunocytochemically in that the anion exchanger AE2 is concentrated at the front of MDCK-F cells. Our findings show that NHE and anion exchanger are distributed in a polarized way in migrating cells. They are consistent with important contributions of both transporters to protrusion of the lamellipodium via solute uptake and consequent volume increase at the front of migrating cells.
Klein
M
M
Physiologisches Institut, D-97070 Würzburg, Germany.
Seeger
P
P
Schuricht
B
B
Alper
S L
SL
Schwab
A
A
D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D017920:Antiporters / Q000378:metabolism*; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D002465:Cell Movement / Q000502:physiology*; D016764:Cell Polarity / Q000502:physiology*; D048429:Cell Size / Q000502:physiology; D027963:Chloride-Bicarbonate Antiporters; D004285:Dogs; D004847:Epithelial Cells / Q000737:chemistry / Q000378:metabolism*; D006146:Guanidines / Q000493:pharmacokinetics; D006863:Hydrogen-Ion Concentration; D036341:Intercellular Signaling Peptides and Proteins; D007668:Kidney / Q000166:cytology; D009997:Osmotic Pressure; D010455:Peptides / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology; D012492:Salts / Q000493:pharmacokinetics; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism*; D013111:Spider Venoms / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology; D013450:Sulfones / Q000493:pharmacokinetics; D014867:Water / Q000378:metabolism
D000889:Anti-Arrhythmia Agents; D017920:Antiporters; D027963:Chloride-Bicarbonate Antiporters; D006146:Guanidines; D036341:Intercellular Signaling Peptides and Proteins; C411249:MTx4 protein, Grammostola spatulata; D010455:Peptides; D012492:Salts; D017923:Sodium-Hydrogen Exchangers; D013111:Spider Venoms; D013450:Sulfones; D014867:Water; C074107:3-methylsulfonyl-4-piperidinobenzoyl guanidine; D000584:Amiloride; C039614:ethylisopropylamiloride